Goldman Sachs Group Inc Karuna Therapeutics, Inc. Put Options Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

May 14, 2024
BUY
$176.32 - $240.22 $863,968 - $1.18 Million
4,900 New
4,900 $1.06 Million
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $863,968 - $1.18 Million
4,900 New
4,900 $1.06 Million
Q3 2021

Nov 10, 2021
BUY
$101.2 - $125.87 $1.52 Million - $1.89 Million
15,000 New
15,000 $1.84 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email